Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bicycle Therapeutics (BCYC) Profit After Tax (2018 - 2025)

Bicycle Therapeutics' Profit After Tax history spans 8 years, with the latest figure at -$20.2 million for Q4 2025.

  • For Q4 2025, Profit After Tax rose 61.13% year-over-year to -$20.2 million; the TTM value through Dec 2025 reached -$219.0 million, down 29.54%, while the annual FY2025 figure was -$219.0 million, 29.54% down from the prior year.
  • Profit After Tax reached -$20.2 million in Q4 2025 per BCYC's latest filing, up from -$59.1 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$14.7 million in Q3 2021 to a low of -$79.0 million in Q2 2025.
  • Average Profit After Tax over 5 years is -$37.4 million, with a median of -$34.5 million recorded in 2022.
  • The largest YoY upside for Profit After Tax was 61.13% in 2025 against a maximum downside of 128.72% in 2025.
  • A 5-year view of Profit After Tax shows it stood at -$18.0 million in 2021, then crashed by 66.27% to -$30.0 million in 2022, then crashed by 64.0% to -$49.1 million in 2023, then dropped by 5.53% to -$51.9 million in 2024, then surged by 61.13% to -$20.2 million in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Profit After Tax are -$20.2 million (Q4 2025), -$59.1 million (Q3 2025), and -$79.0 million (Q2 2025).